William M Testa is listed as an executive officer on 2 SEC Form D filings by 1 issuer between Oct 2010 and Dec 2010: Cahaba Pharmaceuticals, LLC (Princeton, NJ — pharmaceuticals — 2010; $832K reported sold to 1 investors).
What this means One deal on file with the SEC, filed Dec 2010. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Andrew P. Aromando (2 shared filings), J. Rainer Twiford (2 shared filings) and Madding King, III (2 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around William. Each name links to their own page.
The issuer belongs to the sponsor group Brookline (24 issuers, $62.5M reported sold, 2008–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Brookline has 24 companies on file and $62.5M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 7 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for William M Testa and found 6 differences, 1 worth asking the sponsor about: 53% of the money raised went to insiders; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
